ALNH ALNI ALNICO ALNIS ALNK ALNLA ALNM ALNNO ALNO ALNOT ALNP ALNR ALNRS ALNS ALNU ALNY ALO ALOA ALOAF ALOAP ALOAQ ALOBA ALOC ALOCU ALOD ALOE ALOF ALOFT ALOFTS ALOG ALOGE ALOH ALOHA ALOI ALOIS ALOK ALOL ALOM ALOMAR ▼
Ki-67 is a nuclear protein and a proliferation marker frequently used in establishing the prognosis for breast cancer patients. To investigate the prognostic value of the Ki-67 proliferation index in female cats with mammary carcinoma, a prospective study was conducted with 96 animals. The Ki-67...
Wondering what the difference is between STIs (sexually transmitted infections) and STDs (sexually transmitted diseases)? The STI Project is here to give you the low-down! STI and STD are often used interchangeably. More recently, the term STI has risen in popularity over STD in public health...
Cancer 89(8):1845–1853Mandard AM, Denoux Y, Herlin P, et al. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: Multivariate analysis with Ki-67 index, mitotic count, and microvesseldensity. Cancer....
Potassium iodide (KI) is a salt that can help protect you from radioactiveiodine. Yourthyroid glandis the part of your body that’s most sensitive to radioactive iodine. Potassium iodide can help block yourthyroidfrom absorbing radioactive iodine if you are exposed to it. ...
The cancer stem cell concept implies that metastatic spread is, in principle, restricted to CSCs. In fact, metastases show in most cases a higher percentage of TF-positive cells or of TF-positive cases (Cao et al. 1995). Disseminated breast cancer cells in the bone marrow (DTC-BM, identif...
signs. although the progressive nature of the disease is far from being understood, it is clear that by overlooking individuals with histological lesions of psvd in the absence of ph, clinicians may be missing the opportunity for early interception of clinical manifestations and potential ...
What is not included in the out-of-pocket limit? Premiums, and health care services this plan doesn't cover, indicated in chart starting on page 2. Even though you pay these expenses, they don't count toward the out–of–pocket limit. This plan uses a provider network. You will pay ...
The emergence of new novel therapeutic agents which directly target molecules that are uniquely or abnormally expressed in cancer cells (molecular targeted therapy, MTT) has changed dramatically the treatment of cancer in recent years. The clinical benefit associated with these agents is typically limite...
Keywords: neuropathy, cancer pain, coanalgesics Introduction Cancer pain is a serious health problem, and imposes a great burden on the lives of patients and their families. Pain can be encountered in every stage of cancer until the end of life, and may interfere with t...